Total Holdings
64
Portfolio diversification across 64 positions
HELX
(BATS)Franklin Genomic Advancements ETF
$33.43-- (--)
Loading... - Market loading
HELX ETF Holdings: Franklin Genomic Advancements ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$21.58M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
Franklin Templeton
BATS
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Guardant Health, Inc | Stock | 7.41% |
| 2 |  | Natera, Inc. | Stock | 6.69% |
| 3 |  | Krystal Biotech, Inc | Stock | 5.59% |
| 4 |  | Insmed Incorporated | Stock | 4.51% |
| 5 |  | United Therapeutics Corporation | Stock | 4.42% |
| 6 |  | BridgeBio Pharma, Inc. | Stock | 4.19% |
| 7 |  | Ligand Pharmaceuticals Incorporated | Stock | 3.49% |
| 8 |  | Medpace Holdings, Inc | Stock | 3.48% |
| 9 | L LON:AZN | AstraZeneca PLC | Stock | 3.42% |
| 10 | K KO:207940 | Samsung Biologics Co Ltd | Stock | 3.39% |
| 11 |  | Adaptive Biotechnologies Corporation | Stock | 3.35% |
| 12 | L LSE:AZN | AstraZeneca PLC | Stock | 3.31% |
| 13 | K KRX:207940 | Samsung Biologics Co.,Ltd. | Stock | 3.15% |
| 14 |  | Alnylam Pharmaceuticals, Inc | Stock | 3.14% |
| 15 |  | Vertex Pharmaceuticals Incorporated | Stock | 3.01% |
| 16 |  | Eli Lilly and Company | Stock | 2.70% |
| 17 |  | Regeneron Pharmaceuticals, Inc. | Stock | 2.68% |
| 18 |  | Corteva, Inc. | Stock | 2.67% |
| 19 |  | Exact Sciences Corporation | Stock | 2.39% |
| 20 |  | Ionis Pharmaceuticals, Inc | Stock | 2.13% |
| 21 |  | Tempus AI, Inc. Class A Common Stock | Stock | 2.13% |
| 22 |  | BioNTech SE | Stock | 2.04% |
| 23 |  | GRAIL, LLC | Stock | 1.80% |
| 24 | E EBR:ARGX | Argen-X | Stock | 1.69% |
| 25 |  | GeneDx Holdings Corp. | Stock | 1.66% |
| 26 |  | Neurocrine Biosciences, Inc. | Stock | 1.65% |
| 27 |  | Twist Bioscience Corporation | Stock | 1.64% |
| 28 |  | Stoke Therapeutics, Inc. | Stock | 1.56% |
| 29 |  | PTC Therapeutics, Inc. | Stock | 1.48% |
| 30 |  | Travere Therapeutics Inc | Stock | 1.28% |
| 31 |  | Repligen Corporation | Stock | 1.11% |
| 32 |  | Veracyte, Inc | Stock | 1.08% |
| 33 |  | Charles River Laboratories International, Inc | Stock | 1.01% |
| 34 | E ETR:SRT3 | Sartorius Aktiengesellschaft | Stock | 0.99% |
| 35 |  | Danaher Corporation | Stock | 0.95% |
| 36 |  | Thermo Fisher Scientific Inc | Stock | 0.86% |
| 37 |  | Beam Therapeutics Inc | Stock | 0.85% |
| 38 |  | CRISPR Therapeutics AG | Stock | 0.74% |
| 39 |  | IQVIA Holdings Inc | Stock | 0.73% |
| 40 | E ETR:QIA | QIAGEN N.V | Stock | 0.68% |
| 41 |  | Cadence Design Systems, Inc | Stock | 0.68% |
| 42 |  | CareDx, Inc | Stock | 0.64% |
| 43 |  | Jazz Pharmaceuticals plc | Stock | 0.62% |
| 44 |  | Agilent Technologies, Inc | Stock | 0.62% |
| 45 |  | Catalyst Pharmaceuticals Inc | Stock | 0.60% |
| 46 |  | Ultragenyx Pharmaceutical Inc | Stock | 0.52% |
| 47 |  | Arcutis Biotherapeutics, Inc | Stock | 0.48% |
| 48 |  | Axsome Therapeutics, Inc | Stock | 0.46% |
| 49 |  | Praxis Precision Medicines, Inc | Stock | 0.45% |
| 50 |  | Rhythm Pharmaceuticals, Inc | Stock | 0.44% |
Frequently Asked Questions About Franklin Genomic Advancements ETF Holdings
What are the top holdings in HELX?
Franklin Genomic Advancements ETF (HELX) holds 64 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is HELX's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review HELX's holdings table to analyze concentration risk.
What is HELX's sector allocation?
The Sector Allocation chart shows how HELX distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does HELX invest in?
HELX's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is HELX ETF?
HELX's diversification can be assessed by reviewing its 64 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.